Novavaxincis A Biotechnology Company Based In Gaithersburgmarylandspecializing In Vaccinedevelopmentfounded In 1987Thecompany Utilizes Recombinant Nanoparticletechnology And Its Proprietary Matrix Ma C Adjuvant To Createvaccines For Infectious Diseaseswith Research And Manufacturing Facilities In Theu S Swedenand Theczech Republicnovavax Employs Over 1 500 Peopleas Of 2022 Thecompany Gained Prominenceduring Thecovid 19 Pandemic With Its First Commercial Productnuvaxovida Protein Based Vaccineauthorized In Over 40 Countriesnovavax Is Also Developing Additional Covid 19 Vaccinecandidates And Has A Pipelinethat Includes Vaccines For Ebolamerssarsand Influenzathecompany Aims To Address Global Health Challenges Through Vaccineinnovation And Seeks To Expand Its Technology To Benefit Billions Of Lives
No conferences found for this company.
| Company Name | Novavax Cz As |
| Country |
Czech Republic
|
| Address | N/A |
| Telephone | N/A |
| N/A |
